CVS adds 4 new board members in deal with Glenview

CVS makes deal with Glenview Capital, adds four board seats
CVS has had a challenging year. . CVS Health has added Glenview Capital’s CEO and three others to its board in a deal with the hedge fund, a month after the health c
CVS adds four new board members in deal with Glenview as CEO pursues a turnaround
CVS Health added Glenview Capital's top boss and three others to its board in a deal with the hedge fund, a month after the healthcare conglomerate tasked a new CEO with its turnaround efforts.
CVS Adds to Board in Deal With Glenview
Among the new CVS directors is Larry Robbins, chief executive of the hedge fund, which recently took a stake in the healthcare giant.
Activist Investor Glenview Capital Gets Four Seats On CVS Board
The board of directors at CVS is being expanded to 16 members to accommodate the new appointees. The other new directors are Leslie Norwalk, Guy Sansone and Doug Schulman. Glenview Capital has amassed a sizable stake in CVS stock and is agitating for change, including helping to precipitate Lynch's removal as CEO.
CVS Health Adds Four Board Seats In Deal With Hedge Fund
CVS Health said four new members will be added to its board from the hedge fund Glenview Capital, which had been pushing for changes at the diversified healthcare giant.
CVS, Glenview Capital reach deal that adds 4 board members
As CVS Health pushes to turn around its financial fortunes, it has entered into a deal with key investor Glenview Capital Management that will add four members to its board of directors. | As CVS Health pushes to turn around its financial fortunes,
CVS adds Glenview Capital Management founder to board
CVS has withdrawn its guidance for this year and offered investors no outlook for the next amid struggles in both the pharmacy and insurance businesses.
CVS Health names four new board members in deal with activist investor
CVS Health said on Monday it named four new members to its board of directors as part of a deal with activist investor Glenview Capital as the healthcare company continues to fight its way out of its brutal 2024.
CVS adds four new board members in deal with Glenview Capital
CVS Health said on Monday it added four new members to its board including hedge fund Glenview Capital's chief executive Larry Robbins as part of a standstill agreement with the activist investor. Shares of CVS rose 2% to $54.
CVS Health Bulks Its Board up to 16 Members, Adds Hedge Fund CEO
CVS Health has added four new board members, including the CEO of a hedge fund that has been critical of the struggling health care giant
CVS Health bulks its board up to 16 members, adds hedge fund Glenview’s CEO
CVS Health has added four new board members, including the chief executive of a hedge fund that has been critical of the struggling healthcare giant.
The Boston Globe20h
CVS adds Glenview’s Robbins to board under activist pressure
CVS Health Corp. named Glenview Capital Management founder Larry Robbins to its board as part of an agreement with the ...
CVS strikes deal with activist Glenview Capital for four board seats
CVS Health struck a deal with dissident Glenview Capital, giving the investor four board seats. Glenview had been pushing for ...
CVS Health Stock Is Moving Higher Monday: What's Going On?
CVS Health Corporation (NYSE: CVS) shares are trading higher Monday after the company announced the addition of four new directors to its board. Here's what you need to know.